A B S T R A C T Fasted dogs prepared with catheters in the femoral artery, portal vein, and hepatic vein and infused intravenously with palmitate-1-m4C were used to estimate uptake of free fatty acids in liver and their conversion to major metabolic products secreted into hepatic venous blood. Animals were studied under ordinary conditions and when fat mobilization was increased abruptly by infusing norepinephrine or for a prolonged period by withdrawing insulin from depancreatized dogs. 80% of hepatic blood flow was assumed to be derived from the portal vein.
INTRODUCTION
The liver is an important site of removal of free fatty acids (FFA) from blood plasma. In various mammals, one-fourth to one-third of isotopically labeled FFA can be recovered in hepatic lipids shortly after intravenous pulse injection (2) (3) (4) and the liver extracts about the same fraction of labeled FFA from the blood passing through it (5-7). The major pathways taken by FFA entering the liver are reasonably well defined (8) and studies with perfused livers have shown that the extent to which FFA enter these pathways is influenced by nutritional state and other variables (9, 10) . Very little is known about the regulation of hepatic metabolism of FFA in vivo. Here we report studies of intact dogs on the extent to which FFA enter various metabolic pathways in liver.
Animals were studied in the postabsorptive state under ordinary conditions and when mobilization of fat from adipose tissue was increased abruptly (infusion of norepinephrine) or for a prolonged period (uncontrolled diabetes mellitus).
METHODS
Experimental animals and procedures. Three groups of male mongrel dogs weighing [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] kg were studied: (a) healthy dogs fasted for 18 hr; (b) dogs fasted for 18 hr and given a constant intravenous infusion of l-norepinephrine, 0.5 Ag/ min X kg throughout the study; (c) depancreatized dogs fasted 18 hr and deprived of insulin for 48 hr. The diabetic animals were depancreatized at least 2 months earlier and maintained on a diet of horse meat partially digested by incubation with crude pancreatin and given NPH insulin subcutaneously once daily to maintain urinary excretion of glucose below 15 g daily. These animals lost The Journal of Clinical Investigation Volume 49 1970 10-15% of their initial body weight during the 1st month after operation, but their weight was stable for at least 1 month before study. The other dogs were fed a diet containing approximately 75%o protein and 25% fat and had stable weights for at least 2 wk before study.
4-7 days before each experiment, the animals were anesthetized with sodium pentobarbital and a laparotomy was performed. The spleen was removed and a small catheter of Teflon was placed through a branch of the splenic vein so that the tip lay just below the bifurcation of the portal vein as it entered the liver. All animals were eating for 3-4 days before study. The experiments were performed under pentobarbital anesthesia. 50-60 mg/kg were injected intravenously initially and repeated doses of 3-6 mg/kg were given as needed to maintain heart rate below 100 beats/min, respiratory rate below 12/min, and to prevent shivering. Under fluoroscopic control, a catheter of Teflon, 3 mm in diameter and filled with Renografin was placed into a large left hepatic vein through an incision in the right external jugular vein. The tip of the catheter was inserted about 3 cm into the hepatic vein so that free flow of blood was obtained. Patency of this catheter was maintained by a slow infusion of 0.15 M sodium chloride. No heparin was used. A superficial leg vein and a femoral artery were cannulated and a constant infusion of 0.15 M saline containing palmitate-1-1'C bound to human serum albumin (11) , approximately 1 /LCi/ml, and Indocyanine Green (Cardio green) was given through the peripheral venous catheter at a rate of 0.25 ml/min from a pump-driven calibrated syringe. Hepatic venous, portal venous, and arterial blood were sampled simultaneously several times during a period of 3-4 hr. Less than one-fifth of estimated blood volume was removed; this was replaced with 0.15 M sodium chloride. At the end of most experiments, the liver was weighed and samples were taken from four separate lobes for extraction of lipids.
Analyses. Blood samples were collected with glass syringes, placed in tubes containing 0.01 ml sodium heparin (1000 U/ml) per ml blood and chilled in ice. Duplicate 0.05 ml samples were treated with zinc sulfate and barium hydroxide solutions for measurement of glucose (12). 2 ml was rapidly mixed with 2.0 ml of 30% perchloric acid. The resulting protein-free filtrate was brought to pH 7.6 with 20% KOH to minimize decarboxylation of acetoacetate. The remainder of the blood was centrifuged for 20 min at 1000 g at 30C. Samples of the fresh plasma were processed for various analyses on the day of study. Separate samples of blood were taken in duplicate into 2.5-ml plastic syringes containing a small amount of dry heparin. Exactly 2 ml was delivered from the syringe through a long 22-gauge needle into a stoppered Erlenmeyer flask equipped with a center well. The well contained a 3 X 2 cm rectangle of Whatman No. 1 filter paper folded twice on its short axis and impregnated with 0.1 ml of 10 N KOH. The main part of the flask contained 0.3 ml of 5 N H2SO4. Carbon dioxide was allowed to diffuse onto the paper overnight at room temperature. The paper was then removed and placed into counting vials together with 5 ml of methanol used to wash the center well and 10 ml of toluene containing 0.3%o diphenyloxazole was added. Assay of "C was performed with a liquid scintillation spectrometer (13) .
'CO2 derived from decarboxylation of acetoacetate could contaminate this extract. The maximal contribution of 14C from this source was calculated for each experiment and shown to have negligible effect on the reported values for production of "4CO2.
Lipids were extracted from duplicate 1 ml samples of plasma in 5 ml of Dole's mixture (14) . The procedure of Trout, Estes, and Friedberg (15) was used to purify the extract. FFA were titrated in a two-phase system by Dole's method (14) ; FFA and neutral lipids were then separated and assayed for 14C as described previously (16) . Negligible 4C was present in cholesterol esters and in the very small amounts of phospholipid remaining in the neutral lipid fraction during the period of study. For separation of very low density lipoproteins (VLDL), 2-3 ml of plasma was centrifuged in the 40.3 rotor of a Beckman model L ultracentrifuge at 140,000 g for 15-18 hr at 12'C. VLDL were separated with a tube slicer and transfered quantitatively into chloroform-methanol, 2: 1 (v/v). Glyceride glycerol was measured in duplicate samples of the extract after removing phospholipids with silicic acid (17) and on the neutral lipid fraction obtained from Dole's extract. Composition of FFA was measured by gas-liquid chromatography (18) . The neutralized protein-free filtrate of whole blood was used for estimating glycerol, acetoacetate, and fi-hydroxybutyrate.
Glycerol was determined by the enzymatic microfluorimetric method of Chernick (19) triglyceride fatty acids (TGFA), 6%o for TGFA-s"C in whole plasma, 5% for '4CO2, 4%o for glycerol, 3% for acetoacetate, 2% for B-hydroxybutyrate, and 5% for glucose. Calculations: 2 (a) Assuming that 80% of the blood entering the liver is derived from the portal vein and 20% from the hepatic artery (23, 24) , hepatic input of metabolite or 14C was calculated as: p X 0.8 + a X 0.2.
(b) Extraction fraction = (a -v)/a where a is the concentration in blood entering and v the concentration in the vein draining the organ or region.
(c) Transport (uptake or production) of metabolite (except FFA) = concentration in plasma (blood) entering X extraction fraction X hepatic or portal plasma (blood) flow. specific activity VLDL-TGFA 1-kg specific activity FFA entering using the table provided by Zilversmit (26 Table I) . Values for various metabolites did not vary systematically during these studies. In control animals, plasma concentrations of FFA and glycerol were within the accepted normal range and those of VLDL-TGFA and ketones were low. In some samples, acetoacetate was almost undetectable in arterial blood (<0.01 imoles/ ml). In the animals given norepinephrine, it caused rapid and sustained increase in levels of FFA and glycerol. This was accompanied by rapid and comparable increase in levels of acetoacetate and f-hydroxybutyrate but levels of VLDL-TGFA were not altered appreciably. Levels of FFA in diabetic animals were increased to a lesser extent than in norepinephrineinfused ones, but the concentration of ketones was much higher and these animals were consistently hyperlipemic.
RESULTS
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Production and uptake of FFA. Net outflow transport of FFA was increased in norepinephrine-infused and diabetic animals ( Table II) . The composition of FFA determined in these animals was closely similar in the three sites sampled (Table III) , suggesting that the extent to which palmitate was utilized in the extrahepatic splanchnic region and liver was similar to the other major fatty acid constituents. In the extrahepatic splanchnic region, the extraction fraction of palmitate-14C averaged 7% in control animals and was similar in the other groups (Table IV) Table II) , together with the data in Table III demonstrating similarity of composition of FFA in artery, portal vein, and hepatic vein, indicates that in these dogs the liver did not release detectable amounts of FFA into the hepatic venous blood. Fig. 1 shows individual values for FFA-14C in one norepinephrine-infused animal. There were no apparent differences in efficiency of extraction of FFA in the three groups and, in all, about 25% of plasma FFA was taken up by the liver. Thus, the increase in hepatic uptake of FFA was proportional to their increased transport in norepinephrine-infused and diabetic animals. Hepatic oxidative metabolism of FFA. In control animals, about 10% of palmitate-"C extracted by the liver appeared in hepatic venous C02 (Table V and Fig. 1 ). Release of ketones from the liver could account for 12-24% of the FFA taken up. As discussed later, conversion to labeled C02 provides a minimal estimate of total oxidation of FFA. In contrast, production of ketones provides an upper limit to the true value for oxidation of FFA to acetoacetate and P-hydroxybutyrate. From the following considerations, it seems likely that in control and norepinephrine-infused dogs, FFA are the dominant precursors of ketones produced by the liver. First, although there was considerable individual variation, the average increase in production of ketones in norepinephrine-infused dogs was proportional to the increased hepatic uptake of FFA (Table V) . Second, changes in hepatic output of ketones closely followed those in uptake of FFA after infusion of norepinephrine was started (Fig. 2) . In the diabetics, output of ketones could account for about half of FFA uptake. In these animals, the specific activity of f-hydroxybutyrate, measured at the end of the study, was only about 60% of that expected were all the circulating P-hydroxybutyrate derived from a precursor pool in equilibrium with FFA entering the liver. The mean value for oxidation of FFA to ketones, corrected for this estimate, was 33%, a value higher than that observed in all but one of the control and norepinephrine-infused animals. The fraction of FFA converted to 14CO2 was similar in control and norepinephrine-infused animals, but substantially reduced in the diabetics. Production of glucose in diabetic dogs was about twice that of those infused with norepinephrine (Table V) . Hepatic production of triglycerides. An average of 13% of the palmitate-14C taken up by the liver of control dogs appeared in hepatic venous plasma triglycerides (Table VI) . This fraction was similar in norepinephrine-infused dogs, but reduced in the diabetics. The net inflow transport from liver of TGFA derived from FFA was consequently greatly increased in norepinephrineinfused animals, but not in the diabetics. In most animals, transport of VLDL-TGFA, considered to be the fraction containing newly secreted triglycerides, was also measured. Arteriovenous differences for TGFA in this fraction were similar to those for plasma TGFA, CPM (Table VI) . Such calculations were also possible in two of the control animals and agreed well with the estimates based upon fractional conversion of FFA entering the liver to TGFA. In the diabetic animals, the estimates from fractional conversion are subject to large error since they were so low. The low values were, however, confirmed by the alternate estimates, from which fractional conversion can be calculated to be 0.08, 0.03, and 0.02. Both of these estimates assume that FFA entering the liver are the sole precursor of VLDL-TGFA, an assumption for which no evidence is available in the diabetic animals since the terminal specific activities of VLDL-TGFA were only 14-33% that of hepatic venous FFA (Table  VII) . Hepatic content of triglycerides was greatly elevated in the diabetic animals (Table VIII) and their specific activity was usually lower than that of VLDL-TGFA. In the norepinephrine-infused and diabetic animals, the amount of palmitate-1-14C in hepatic lipids at the end of the study was measured. This quantity, added (Table  VIII) . Extrahepatic splanchnic metabolism. Oxidation of palmitate-14C to C02 was observed in all groups (Table  IV and Fig. 1 ). Uptake of ketones was too small to measure in control animals but was readily shown in the other groups (Table IX) . The fraction of ketones extracted was much lower in diabetic than in norepinephrine-infused animals. Uptake of TGFA-1'C was demonstrable in norepinephrine-infused dogs but not in the other two groups.
Metabolism of glycerol. In all groups of animals, the extrahepatic splanchnic region (Table IX) (Table II) about two-thirds of the glycerol entering their vascular beds. Thus, the liver accounted for about 80% of net splanchnic uptake. The efficiency and narrow range of variation of hepatic uptake of glycerol served as a useful check on correct placement of the hepatic venous catheter.
DISCUSSION
The three-catheter preparation used in this study is more complicated than that used by others (27) to study hepatic metabolism in intact animals. We elected not to use an Eck fistula preparation in order to preserve potentially crucial functional relationships, such as primary delivery of pancreatic endocrine secretions to the liver, and to determine whether certain rates could be determined without sampling portal venous blood. -550  1020  Diabetic  17  135  2960  460  450  500  18  140  4520  640  510  170  19  180  2990  980  690  170 * Mean values (cpm/jsmole) during last hour of study. Our assumption that 80% of hepatic blood flow derived from the portal vein is based upon measurements with electromagnetic flowmeters in pentobarbital-anesthetized dogs before and during infusion of norepinephrine (23, 24) . A greater fraction may derive from the hepatic artery in conscious animals (28) . It might have been more desirable to determine portal and hepatic arterial flow separately. Whether distribution of hepatic arterial and portal venous flow through the hepatic lobule differs is not certain (29) (30) (31) , so estimates of transport of metabolites based upon any measure of distribution of flow between portal vein and hepatic artery may be subject to an error for which there is no obvious remedy. For all the substances studied here (excepting extrahepatic production of FFA) contribution of the liver to uptake or production considerably exceeded that of the extrahepatic splanchnic region. Therefore, differing estimates of distribution of inflowing blood to the liver have only a small influence on calculated hepatic fluxes. For example, were the fraction of hepatic blood flow contributed by the hepatic artery 33% rather than 20%, our estimates of hepatic extraction of palmitate-14C would increase about 10%.
Our results confirm earlier studies with respect to extraction fraction of FFA in liver (5-7) and the fraction of plasma FFA which is taken up in the Our data do not establish that ketones produced by the liver were derived entirely from FFA in the dogs infused with norepinephrine, but the rapid and proportionate increase in uptake of FFA and production of ketones suggests that this is the case. In postabsorptive humans given palmitate-1-14C intravenously, measurements of specific activities indicate that plasma FFA are the sole precursors of the carbonyl carbon of acetoacetate.' As discussed below, measurements of hepatic production of 14CO2 provide minimal estimates of complete oxidation of FFA. Thus, quantitative interpretation of measurements of fractional oxidation of FFA is not possible. The reasonably good recovery of 14C taken up by the liver as stored or secreted products (Table VIII) does suggest that the overall estimates are not grossly in error. The large fraction of FFA stored in hepatic lipids of control and norepinephrine-infused animals suggests net accumulation of triglycerides during the experimental periods. This is consistent with reports that hepatic triglyceride content increases during fasting (3) and that this process is accelerated when fat mobilization is increased further by norepinephrine (33, (35) .
The diabetic dog presents a considerably more complex situation. In these animals, it may be assumed that prolonged deficiency of insulin had led to increased rate of the gluconeogenesis (36) . These animals had grossly fatty livers and their ketosis was out of proportion to the rate of fat mobilization. The magnitude of the ketonemia is explained, in part, by the observation that hepatic production of ketones was greater than expected from the rate of hepatic uptake of FFA. The fractional extraction of ketones in the extrahepatic splanchnic region was much lower in diabetic than in norepinephrine-infused animals; this suggests that peripheral utilization of ketones was also impaired. In studies inspired by these observations it has been shown that utilization of ketones is impaired in such diabetic dogs.' Our data also indicate that not all ketones produced by the livers of the diabetic dogs were derived immediately from plasma FFA. Two additional sources must be considered. First, ketones could be derived from fattv acids contained in the large quantity 6f triglyceride stored in these livers. As shown in Table VII , hepatic triglyceride pools of very low specific activity were present. Second, they could be derived from ketogenic amino acids as part of the general increase in protein catabolism characteristic of uncontrolled diabetes. The first possibility is supported by the observations of Heimberg and his associates (37, 38) . They observed decreasing content of hepatic triglycerides together with high rates of production of ketones when livers from alloxan diabetic rats were perfused with small quantities of palmitic acid.
Relatively less palmitate was oxidized to C02 than to ketones in the diabetic than in the control and norepinephrine-infused animals (Table V) . In the latter two, the ratio, production ketone carbon: production C02, varied between 0.6 and 3.9 (mean 1.8) while in the former it varied from 5.4 to 16 (mean 9.4). Earlier studies in simpler systems have suggested that accelerated oxidation of fatty acids may be accompanied by in-'Balasse, E. O., and R. J. Havel. To be published. creased fractional conversion of resulting acetyl CoA to ketones (39 The estimate of hepatic production of VLDL-TGFA in diabetic dogs presents some similar problems. Clearly, a very small fraction of FFA taken up in their livers was released in triglycerides. However, it is not certain that FFA were the sole precursors of plasma TGFA, particularly since this did not appear to be the case for ketones. It is not known whether fatty acids arising from hydrolysis of stored triglycerides in liver enter a pathway leading to secretion of VLDL-TGFA, but there is no evidence to discount such a possibility. If it is assumed that the specific activities of P-hydroxybutyrate in these dogs (Table V) equal that of the precursor pool for VLDL-TGFA, the production rates shown in Table VI underestimate the actual values by about 40%. The data do, however, permit the conclusion that the hyperlipemia in these animals was not primarily the consequence of increased hepatic production of triglycerides. This is consistent with the observation that incorporation of palmitate-1-14C into VLDL-TGFA is decreased in perfused livers from alloxan-diabetic rats (38) . Other data in experimental animals (41) and in man (42) indicate that peripheral utilization of plasma triglycerides is impaired by prolonged deficiency of insulin. In contrast, we have observed that in short-term insulin deficiency in dogs, produced by injection of anti-insulin serum, hyperlipemia is accompanied by increased hepatic production of triglycerides.' Our present results as well as others in man (43, 44) indicate that changes in concentration of triglycerides in blood plasma in states of increased fat mobilization may provide little indication of their hepatic production rate.
Like FFA, utilization of glycerol was proportional to arterial level in liver and extrahepatic splanchnic tissues in the three groups of animals. Fractional extraction was higher in liver, but uptake in intestinal mucosa, which contains an active glycerokinase (45) , may have been comparably high, since only a fraction of portal blood drains this tissue and glycerol presumably was released with FFA from splanchnic adipose tissue.
